Reckitt Benckiser Group plc (LON:RKT – Get Free Report) dropped 1.4% during mid-day trading on Friday . The stock traded as low as GBX 4,495 ($59.38) and last traded at GBX 4,514 ($59.63). Approximately 5,141,905 shares were traded during mid-day trading, an increase of 44% from the average daily volume of 3,572,513 shares. The stock had previously closed at GBX 4,576 ($60.45).
Analysts Set New Price Targets
A number of brokerages have commented on RKT. Berenberg Bank lifted their price target on Reckitt Benckiser Group from GBX 5,100 ($67.37) to GBX 5,200 ($68.69) and gave the stock a “hold” rating in a research report on Wednesday, July 24th. Jefferies Financial Group reiterated a “hold” rating and issued a GBX 4,400 ($58.12) target price on shares of Reckitt Benckiser Group in a research report on Monday, July 29th. Finally, JPMorgan Chase & Co. lowered shares of Reckitt Benckiser Group to a “neutral” rating in a research report on Friday, August 30th.
Check Out Our Latest Stock Report on RKT
Reckitt Benckiser Group Price Performance
Reckitt Benckiser Group Cuts Dividend
The business also recently disclosed a dividend, which was paid on Friday, September 13th. Shareholders of record on Thursday, August 1st were given a GBX 80.40 ($1.06) dividend. The ex-dividend date of this dividend was Thursday, August 1st. This represents a yield of 1.82%. Reckitt Benckiser Group’s dividend payout ratio is presently 9,032.26%.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Recommended Stories
- Five stocks we like better than Reckitt Benckiser Group
- Investing In Preferred Stock vs. Common Stock
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- Upcoming IPO Stock Lockup Period, Explained
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Insider Buying Explained: What Investors Need to Know
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.